CrossrefInfokarte
Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey
Generics and Biosimilars Initiative Journal · 2017-06-15 · 6 (2) · 79-88
DOI: 10.5639/gabij.2017.0602.015 ↗Abstract
Kein Abstract verfügbar.
EUVIMED